Literature DB >> 17370039

Autocrine motility-stimulatory pathways of oral premalignant lesion cells.

M Rita I Young1, Brad W Neville, Angela C Chi, Deanne M R Lathers, M Boyd Gillespie, Terry A Day.   

Abstract

Patients with premalignant oral lesions have varying levels of risk of developing oral squamous cell carcinoma (OSCC), whose aggressiveness requires increased motility. Not known is if and how premalignant oral lesion cells acquire the increased motility characteristic of OSCC. This was addressed by immunohistochemical analysis of banked premalignant lesion tissues and by functional analyses using cultures established from premalignant oral lesions and OSCC. These studies showed premalignant oral lesion cells and OSCC to be more motile than normal keratinocytes. Concomitantly, levels of ceramide were reduced. The activity of the protein phosphatase PP-2A, which restricts motility and which can be activated by ceramide, was also diminished. This was due to IL-10 released from premalignant lesion cells. Treatment with a membrane-permeable ceramide restored PP-2A activity and blocked migration. These studies show an autocrine motility-stimulatory pathway that is mediated in premalignant lesion cells by IL-10 through its reduction of ceramide levels and inhibition of PP-2A activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17370039     DOI: 10.1007/s10585-007-9063-0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   4.510


  29 in total

1.  Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex.

Authors:  F Vazquez; S R Grossman; Y Takahashi; M V Rokas; N Nakamura; W R Sellers
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

2.  Use of okadaic acid to inhibit protein phosphatases in intact cells.

Authors:  D G Hardie; T A Haystead; A T Sim
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 3.  Tumor invasion: role of growth factor-induced cell motility.

Authors:  A Wells
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

4.  Human acid ceramidase is overexpressed but not mutated in prostate cancer.

Authors:  R S Seelan; C Qian; A Yokomizo; D G Bostwick; D I Smith; W Liu
Journal:  Genes Chromosomes Cancer       Date:  2000-10       Impact factor: 5.006

5.  Akt activation correlates with adverse outcome in tongue cancer.

Authors:  Erminia Massarelli; Diane D Liu; J Jack Lee; Adel K El-Naggar; Lorenzo Lo Muzio; Stefania Staibano; Sabino De Placido; Jeffrey N Myers; Vassiliki A Papadimitrakopoulou
Journal:  Cancer       Date:  2005-12-01       Impact factor: 6.860

6.  Interleukin-10 and interleukin-13 inhibit proinflammatory cytokine-induced ceramide production through the activation of phosphatidylinositol 3-kinase.

Authors:  K Pahan; M Khan; I Singh
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

7.  Protein phosphatase-2A maintains focal adhesion complexes in keratinocytes and the loss of this regulation in squamous cell carcinomas.

Authors:  Alex A Romashko; M Rita I Young
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  Ceramide activates heterotrimeric protein phosphatase 2A.

Authors:  R T Dobrowsky; C Kamibayashi; M C Mumby; Y A Hannun
Journal:  J Biol Chem       Date:  1993-07-25       Impact factor: 5.157

9.  Immunohistochemical localization of interleukin-10 in human oral and pharyngeal carcinomas.

Authors:  Stephen W Chandler; Christopher H Rassekh; Susan M Rodman; Barbara S Ducatman
Journal:  Laryngoscope       Date:  2002-05       Impact factor: 3.325

10.  Overcoming resistance to gamma-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels.

Authors:  Gersende Alphonse; Clara Bionda; Marie-Thérèse Aloy; Dominique Ardail; Robert Rousson; Claire Rodriguez-Lafrasse
Journal:  Oncogene       Date:  2004-04-08       Impact factor: 9.867

View more
  3 in total

Review 1.  Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.

Authors:  Thomas H Beckham; Saeed Elojeimy; Joseph C Cheng; Lorianne S Turner; Stanley R Hoffman; James S Norris; Xiang Liu
Journal:  Expert Opin Ther Targets       Date:  2010-05       Impact factor: 6.902

2.  C2-ceramide induces cell death and protective autophagy in head and neck squamous cell carcinoma cells.

Authors:  Wenyuan Zhu; Xinhua Wang; Yi Zhou; Huiming Wang
Journal:  Int J Mol Sci       Date:  2014-02-21       Impact factor: 5.923

3.  Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma.

Authors:  Yujuan Sun; Nan Liu; Xiaobing Guan; Hongru Wu; Zheng Sun; Hui Zeng
Journal:  Mediators Inflamm       Date:  2016-12-08       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.